Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Film dosage form with extended release mucoadhesive particles

a film and mucoadhesive technology, applied in the direction of organic active ingredients, ether/acetal active ingredients, pharmaceutical non-active ingredients, etc., can solve the problems of difficult and expensive production of multiple layer film dosage forms for achieving sustained release of active agents for local delivery in the buccal cavity, and provide a palpable sensation that many patients find undesirable, so as to facilitate controlled effect and avoid discomfor

Active Publication Date: 2017-06-06
INTELGENX CORP
View PDF25 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a new way to release an active ingredient in the mouth over a period of time without causing discomfort. This is done by creating small particles that contain the ingredient and placed in a film that can be dissolved in the mouth. The particles are designed to stick to the mouth lining and release the ingredient slowly over time. This new way of delivering active ingredients makes them more effective and comfortable to use.

Problems solved by technology

As a result, multiple layer film dosage forms for achieving sustained release of an active agent for local delivery in the buccal cavity can be difficult and expensive to produce.
Multiple-layer, sustained-release film oral dosage forms can also be annoying to some patients, as the film dosage form must be retained in the oral cavity for an extended period, all the while providing a palpable sensation that many patients find undesirable.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013]The disclosed orally administrable dosage forms can be used to provide sustained release of an agent that is delivered for local action in the buccal cavity or under the tongue. The dosage forms can be employed in a variety of treatments in which release of a particular active agent in the buccal cavity or under the tongue over a prolonged period of time provides a beneficial effect. Examples include treatment of gingivitis, buccal ulcers, canker sores, Sjögren's syndrome, oral mucositis, and Behçet's disease.

[0014]Sustained release delivery of an agent for local delivery in the buccal cavity is achieved with a dosage form that is essentially imperceptible to the patient. Rather than leaving a mucoadhesive film or patch of substantial size on the oral mucosa during the duration of the extended treatment, the active agent is released from mucoadhesive particles that are adhered to oral mucosa and are of a size that is essentially unnoticeable to the patient. The term “particle”...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of U.S. Provisional Application No. 61 / 910,604, filed Dec. 2, 2013, which is incorporated herein by reference.FIELD OF THE DISCLOSURE[0002]This disclosure relates generally to controlled release oral dosage forms, especially those oral dosage forms releasing an active agent for local delivery in the buccal cavity.BACKGROUND OF THE DISCLOSURE[0003]Film dosage forms that provide extended release of an active agent have been known. Such film dosage forms are known to comprise at least two layers, which include at least one mucoadhesive layer to facilitate adhesion of the dosage form to mucosa for an extended period, and a layer that acts as a diffusion barrier that prevents or restricts loss of the active agent from the dosage form to saliva in the oral cavity and ultimately to the gastrointestinal tract. The active agent can be located in the mucoadhesive layer or in a third, reservoir layer between the m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): A61K47/32A61K31/09A61K31/155A61K9/00
CPCA61K9/006A61K31/09A61K31/155A61K47/32
Inventor OBEID, RODOLPHEPAIEMENT, NADINE
Owner INTELGENX CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products